Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jordan T. Moore"'
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: CD38 is a transmembrane glycoprotein that catabolizes nicotinamide adenine dinucleotide (NAD+) and is the main source for the age-dependent decrease in NAD+ levels. Increased CD38 enzymatic activity has been implicated in several neurolog
Externí odkaz:
https://doaj.org/article/2000f9805f9d49a2bf2beea6d965b34a
Autor:
Cellas A Hayes, Jordan T Moore, Colwyn A Headley, Almarely L Berrios-Negron, W Marcus Lambert
Publikováno v:
eLife, Vol 13 (2024)
Many successful researchers in the biomedical sciences have benefitted from mentors and networks earlier in their career. However, early-career researchers from minoritized and underrepresented groups do not have the same access to potential mentors
Externí odkaz:
https://doaj.org/article/c77f89806bb84a6faf115b40058f9a44
Autor:
Luke R. Lemmerman, Jordan T. Moore, Erin R. Goebel, Aidan J. Maxwell, Jordan Deguzman, Daniel Gallego-Perez
Publikováno v:
Nanomedicine ISBN: 9789811393747
Nanomedicine ISBN: 9789811689833
Nanomedicine ISBN: 9789811689833
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74cdec22c8edc558f8c278ed771c09ea
https://doi.org/10.1007/978-981-13-9374-7_21-1
https://doi.org/10.1007/978-981-13-9374-7_21-1
Autor:
Daniel J. Dodd, Cameron Rink, William Lawrence, Daniel Gallego-Perez, Craig Mathews, Jordan T. Moore, Diego Alzate-Correa, Natalia Higuita-Castro, Devleena Dasgupta, Ian L. Valerio
Publikováno v:
Nanotechnology and Microfluidics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb420dea20326254100a63a713e06b4c
https://doi.org/10.1002/9783527818341.ch12
https://doi.org/10.1002/9783527818341.ch12
Publikováno v:
Stroke. 52
Introduction: Nitric oxide (NO) has been implicated in the pathogenesis of cerebral small vessel disease (cSVD). NO is produced by three NO synthase (NOS) isoforms including endothelial (eNOS), neuronal (nNOS), and inducible (iNOS). While eNOS has be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b8aed37a73f10ff420c73a59c5537ac
https://doi.org/10.1161/str.52.suppl_1.p51
https://doi.org/10.1161/str.52.suppl_1.p51
Publikováno v:
Stroke. 52
Introduction: Neurovascular unit (NVU) dysfunction plays a key role in cerebral small vessel disease (cSVD) pathogenesis. Spontaneously Hypertensive Rats - Stroke Prone (SHRSP) is a relevant model for cSVD where prominent impairment of the NVU has be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c40716fcdfccc77185429f269d3b92df
https://doi.org/10.1161/str.52.suppl_1.p54
https://doi.org/10.1161/str.52.suppl_1.p54
Autor:
Dana M. McTigue, Chandan K. Sen, Aidan J. Maxwell, Daniel Gallego-Perez, Jordan T. Moore, Luke R. Lemmerman, Lilibeth Ortega-Pineda, Gina P. Guio-Vega, Hallie Harris, Lauren Wilch, Diego Alzate-Correa, Savita Khanna, Maria Angelica Rincon-Benavides, Ian B. Risser, Daniel J. Dodd, Maria H.H. Balch, W. David Arnold, Shahid M Nimjee, Ana Salazar-Puerta, Silvia Duarte-Sanmiguel, Surya Gnyawali, Cameron Rink, William Lawrence, Natalia Higuita-Castro
Publikováno v:
Science Advances
Fibroblasts nonvirally programmed to convert into induced endothelial cells show therapeutic potential for ischemic stroke.
Ischemic stroke causes vascular and neuronal tissue deficiencies that could lead to substantial functional impairment and
Ischemic stroke causes vascular and neuronal tissue deficiencies that could lead to substantial functional impairment and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41c8c008e4d843e7523217c5981ddb3c
http://europepmc.org/articles/PMC7978431
http://europepmc.org/articles/PMC7978431
Autor:
William E. Carson, Brooke Benner, Vasudha C. Shukla, Ana Panic, Samir N. Ghadiali, Christopher M Bobba, Silvia Duarte-Sanmiguel, Daniel Gallego-Perez, Jordan T. Moore, Abirami Senthilvelan
Publikováno v:
Adv Biosyst
Myeloid derived suppressor cells (MDSCs) have gained significant attention for their immunosuppressive role in cancer and their ability to contribute to tumor progression and metastasis. Understanding the role of MDSCs in driving cancer cell migratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::804e21f21cb7f975b26aa1c475e994fe
https://europepmc.org/articles/PMC7489303/
https://europepmc.org/articles/PMC7489303/
Autor:
Michael R. Go, Heather M. Powell, Andre F. Palmer, Daniel Gallego-Perez, Jordan T. Moore, Xiangming Gu, Ludmila Diaz-Starokozheva, Devleena Das, Natalia Higuita-Castro, Ian L. Valerio, Luke R. Lemmerman
Publikováno v:
Cell Mol Bioeng
BACKGROUND: Tissue ischemia contributes to necrosis and infection. While angiogenic cell therapies have emerged as a promising strategy against ischemia, current approaches to cell therapies face multiple hurdles. Recent advances in nuclear reprogram
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c1e5e5ef2ca40278da9eb55892b6b7c
https://pubmed.ncbi.nlm.nih.gov/33184576
https://pubmed.ncbi.nlm.nih.gov/33184576
Autor:
Daniel Gallego-Perez, Jordan T. Moore, Gina P. Guio-Vega, Brooke Benner, Ana Panic, William Lawrence, Silvia Duarte-Sanmiguel, Natalia Higuita-Castro, Luke R. Lemmerman, William E. Carson, Samir N. Ghadiali, Vasudha C. Shukla, Shipeng Wang, Nicholas Idzkowski
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Myeloid-derived suppressor cells (MDSCs) are immune cells that exert immunosuppression within the tumor, protecting cancer cells from the host’s immune system and/or exogenous immunotherapies. While current research has been mostly focused in count
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::802bfc9b784df01a7b0069c31230d3fa
http://europepmc.org/articles/PMC6985212
http://europepmc.org/articles/PMC6985212